CPB2, carboxypeptidase B2, 1361

N. diseases: 148; N. variants: 11
Disease: Polyendocrinopathies, Autoimmune ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0085409
Disease: Polyendocrinopathies, Autoimmune
Polyendocrinopathies, Autoimmune 		0.030 Biomarker group BEFREE Thus, TAFIa may be considered a novel biomarker for arterial thrombosis in APS. 28669410 2017
CUI: C0085409
Disease: Polyendocrinopathies, Autoimmune
Polyendocrinopathies, Autoimmune 		0.030 GeneticVariation group BEFREE We investigated clot lysis time, thrombin activatable fibrinolysis inhibitor antigen (TAFI) levels and TAFI gene polymorphisms in pregnant patients with severe preeclampsia, with or without associated antiphospholipid syndrome (APS). 20594598 2010
CUI: C0085409
Disease: Polyendocrinopathies, Autoimmune
Polyendocrinopathies, Autoimmune 		0.030 Biomarker group BEFREE Basal TAFI and CLT in patients with APS having an adverse or a good obstetrical outcome were similar. 19895374 2009